In their study on Th 1 and Th 17 hypercytokinemia in severe pandemic infl uenza, Bermejo-Martin and colleagues [1] observed signifi cantly elevated levels of IL-17 and par ticularly IL-6 in critically ill patients. Th ey also reported that up to 50% of critical care patients studied were obese.
In their study on Th 1 and Th 17 hypercytokinemia in severe pandemic infl uenza, Bermejo-Martin and colleagues [1] observed signifi cantly elevated levels of IL-17 and par ticularly IL-6 in critically ill patients. Th ey also reported that up to 50% of critical care patients studied were obese.
Correale and colleagues [2] indicate that activated vitamin D enhances the development of IL-10-producing cells and reduces the number of IL-6-and IL-17-secreting cells. Studies show that obese and overweight individuals are more likely to have an inadequate vitamin D status [3, 4] . According to Louie and colleagues [5] , diabetes and obesity were the most frequently identifi ed underlying conditions in fatal pandemic 2009 infl uenza A (H1N1) infection cases older than age 20 years world wide. In addition, obese people usually have high calorie and low nutritional value diets. Aasheim and colleagues [6] showed that low concentrations of vitamin B-6, vitamin C, 25-hydroxyvitamin D, and vitamin E adjusted for lipids are prevalent in morbidly obese Norwegian patients seeking weight-loss treatment.
It would be interesting to see if any of the critical cases observed in the study by Bermejo-Martin and colleagues were insuffi cient or defi cient in vitamin D and/or other nutrients relevant for intracellular signaling involved in infl ammation. If vitamin D plays a role in human general capacity to deal with infection and other diseases, then an increase in Th 17 mediators in severe pandemic infl uenza patients could be, at least in part, related to vitamin D insuffi ciency/defi ciency. 
Authors' response

Jesus F Bermejo-Martin and the SEMICYUC H1N1 working group
We appreciate Dr Krstić's comment on our article on Th 1-Th 17 hypercytokinemia in severe pandemic infl uenza, recently published in Critical Care. Dr Krstić points to defi ciency of vitamin D as a potential actor in the disregulation of the immune response to the new virus. In our opinion, this could represent a new avenue to be explored in the pathogenesis of the disease. Nonetheless, some questions come to mind. If obesity is related to a defi cient state of vitamin D, and, as a consequence, this defi ciency could infl uence the infl ammatory response to the virus, higher numbers of critically ill H1N1 patients should be observed in western countries, where obesity is widely present. Other countries should also account for increased numbers of critical patients due to vitamin D defi ciency: developing countries or those with limited exposure to sun light are two examples. So far, data do not seem to support an overwhelming increased incidence of severe H1N1 disease in these nations. In our view, vitamin D defi ciency could be involved in the genesis of severe infl uenza disease, but host factors, such as key polymorphisms in the genes responsible for the response to the virus, are the major players in this disease [7] , probably combined with the presence of altered physiological states (increased release of proinfl ammatory mediators from adypocytes in obese patients [8] , immune dysregulation in pregnancy [9] , mucosal infl amation in chronic obstructive pulmonary disease and smokers [10] , and so on). Vitamin D should thus be considered in the context of a wider spectrum of factors infl uencing severe disease.
